Evaluation of injection site reactions caused by Fulvestrant injection and investigation of safe and reliable administration methods

Evaluation of injection site reactions caused by Fulvestrant injection and investigation of safe and reliable administration methods - Evaluation of Fulvestrant injection site

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000055844

Enrollment

Registered

2024-10-15

Start date

2024-10-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Ultrasound examination of the injection site

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Breast cancer patients receiving fulvestrant

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Ultrasound findings at the injection site	—

Countries

Japan

Contacts

Public ContactNana Kamikura

Breast and Imaging Center, St. Marianna University School of Medicine, Kawasaki-Shi, Japan Nursing care

n.kamikura@marianna-u.ac.jp044-969-7720

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026